| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.XPHS.2020.10.048 |
| P698 | PubMed publication ID | 33129837 |
| P2093 | author name string | Lei Liu | |
| Qi Cui | |||
| Li-Li Guan | |||
| Hong-Xia Ma | |||
| Qi-Jun Xu | |||
| Ling-Cong Kong | |||
| Xiu-Yun Jiang | |||
| Muhammad Inam | |||
| P2860 | cites work | Roles of d-Amino Acids on the Bioactivity of Host Defense Peptides | Q26744734 |
| PEGylation, successful approach to drug delivery | Q28278538 | ||
| Antimicrobial peptides in insects; structure and function | Q33699518 | ||
| Structures of β-hairpin antimicrobial protegrin peptides in lipopolysaccharide membranes: mechanism of gram selectivity obtained from solid-state nuclear magnetic resonance. | Q34709011 | ||
| Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances | Q34750112 | ||
| Pegfilgrastim administered once per cycle reduces incidence of chemotherapy-induced neutropenia | Q35024477 | ||
| Effect of pegylation on pharmaceuticals | Q35075776 | ||
| Cloning, expression, and purification of a new antimicrobial peptide gene from Musca domestica larva | Q35206494 | ||
| Identification of a novel cathelicidin antimicrobial peptide from ducks and determination of its functional activity and antibacterial mechanism | Q35853185 | ||
| Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity. | Q36181061 | ||
| Strategies to improve plasma half life time of peptide and protein drugs | Q36452632 | ||
| Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition. | Q36701111 | ||
| Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery. | Q39376740 | ||
| Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. | Q39690252 | ||
| Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides | Q40190665 | ||
| PEGylation of the peptide Bac7(1-35) reduces renal clearance while retaining antibacterial activity and bacterial cell penetration capacity | Q41375616 | ||
| PEGylation prolongs the pulmonary retention of an anti-IL-17A Fab' antibody fragment after pulmonary delivery in three different species | Q42802961 | ||
| Structure and fungicidal activity of a synthetic antimicrobial peptide, P18, and its truncated peptides | Q44823405 | ||
| PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative | Q46632762 | ||
| Novel reagents for human prolactin research: large-scale preparation and characterization of prolactin receptor extracellular domain, non-pegylated and pegylated prolactin and prolactin receptor antagonist | Q47251978 | ||
| Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1. | Q48366454 | ||
| Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation. | Q50862373 | ||
| Comparison of site-specific PEGylations of the N-terminus of interferon beta-1b: selectivity, efficiency, and in vivo/vitro activity. | Q51766541 | ||
| A novel tool against multiresistant bacterial pathogens - lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics. | Q54236921 | ||
| Discovery of linear low-cationic peptides to target methicillin-resistant Staphylococcus aureus in vivo | Q58099768 | ||
| Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin | Q79926448 | ||
| Antibacterial and anti-biofilm activity, and mechanism of action of pleurocidin against drug resistant Staphylococcus aureus | Q90217899 | ||
| Pre-clinical compartmental pharmacokinetic modeling of 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) as a photosensitizer in rat plasma by validated HPLC method | Q90876130 | ||
| Antibacterial activity and its mechanisms of a recombinant Funme peptide against Cronobacter sakazakii in powdered infant formula | Q91335111 | ||
| Liquid chromatography-tandem mass spectrometry based method development and validation of S016-1271 (LR8P), a novel cationic antimicrobial peptide for its application to pharmacokinetic studies | Q92241697 | ||
| From Synthesis to Characterization of Site-Selective PEGylated Proteins | Q92535661 | ||
| Molecular mechanism of vSGLT inhibition by gneyulin reveals antiseptic properties against multidrug-resistant gram-negative bacteria | Q92674005 | ||
| Long-Acting HIV-1 Fusion Inhibitory Peptides and their Mechanisms of Action | Q93081356 | ||
| Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria | Q95279042 | ||
| A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens | Q95329063 | ||
| Recombinant expression, purification and PEGylation of Paneth cell peptide (cryptdin-2) with value added attributes against Staphylococcus aureus | Q97653000 | ||
| P921 | main subject | pharmacokinetics | Q323936 |
| antimicrobial peptide | Q1201508 | ||
| P577 | publication date | 2020-10-28 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Preparation, Characterization and Pharmacokinetic study of N-Terminal PEGylated D-form Antimicrobial Peptide OM19r-8 |
Search more.